Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis

Obsessive-Compulsive Disorder Clinical Trial

Official title:

Research on the Efficacy Mechanism of Natural Psychotherapy for Neurosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05552014
• Other study ID #: CASPsy5
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2022
• Est. completion date: June 1, 2024

Study information

• Verified date: September 2022
• Source: Beijing HuiLongGuan Hospital
• Contact: Xiang Y Zhang, M.D., Ph.D
• Phone: +86-10-62710644
• Email: zhangxy[@]psych.ac.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: June 1, 2024
• Est. primary completion date: December 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 50 Years

Eligibility

Inclusion Criteria:

• Have a diagnosis of obsessive-compulsive disorder or compulsive behavior

• Duration of symptoms for not less than 12 months

• Age 15-50 years old.

• You can participate in the whole experiment and offline assessment in Beijing

Exclusion Criteria:

• Documented disease of physical diseases including, but not limited to stroke, tumor, Parkinson's disease, Huntington's disease, seizure, epilepsy, history of brain trauma

• Subjects who suffered from alcohol or illegal drug abuse/dependence

Related Conditions & MeSH terms

• Obsessive-Compulsive Disorder

Intervention

Behavioral:
• Natural Psychotherapy
Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.
• Mental Health Education
Mental Health Education Seminar

Locations

Country	Name	City	State
China	Institute of Psychology, Chinese Academy of Sciences	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Beijing HuiLongGuan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical symptoms	Obsessive-compulsive symptoms were assessed according to the Obsessive-Compulsive Scale	12 weeks
Primary	Cognitive function	Cognitive function as assessed by RBANS	12 weeks
Primary	Prospective memory	Whether the patient's prospective memory is effectively improved using EEG and NMR	12 weeks
Primary	Mood and behavior	Mood changes judged using gait and face recognition	12 weeks